|
1
|
Yang Q, Graham TE, Mody N, et al: Serum
retinol binding protein 4 contributes to insulin resistance in
obesity and type 2 diabetes. Nature. 436:356–362. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fukuhara A, Matsuda M, Nishizawa M, et al:
Visfatin: a protein secreted by visceral fat that mimics the
effects of insulin. Science. 307:426–430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klein J, Perwitz N, Kraus D and Fasshauer
M: Adipose tissue as source and target for novel therapies. Trends
Endocrinol Metab. 17:26–32. 2006.PubMed/NCBI
|
|
4
|
Filippatos TD, Derdemezis CS, Kiortsis DN,
Tselepis AD and Elisaf MS: Increased plasma levels of
visfatin/pre-B cell colony-enhancing factor in obese and overweight
patients with metabolic syndrome. J Endocrinol Invest. 30:323–326.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tilg H and Moschen AR: Adipocytokines:
mediators linking adipose tissue, inflammation and immunity. Nat
Rev Immunol. 6:772–783. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masaki T, Anan F, Tsubone T, et al:
Retinol binding protein 4 concentrations are influenced by renal
function in patients with type 2 diabetes mellitus. Metabolism.
57:1340–1344. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wajchenberg BL: Subcutaneous and visceral
adipose tissue: their relation to the metabolic syndrome. Endocr
Rev. 21:697–738. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bjorntorp P: Adipose tissue distribution
and function. Int J Obes. 15(Suppl 2): 67–81. 1991.
|
|
9
|
Tchernof A and Poehlman ET: Effects of the
menopause transition on body fatness and body fat distribution.
Obes Res. 6:246–254. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carr MC: The emergence of the metabolic
syndrome with menopause. J Clin Endocrinol Metab. 88:2404–2411.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tchernof A, Desmeules A, Richard C, et al:
Ovarian hormone status and abdominal visceral adipose tissue
metabolism. J Clin Endocrinol Metab. 89:3425–3430. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mizutani T, Nishikawa Y, Adachi H, et al:
Identification of estrogen receptor in human adipose tissue and
adipocytes. J Clin Endocrinol Metab. 78:950–954. 1994.PubMed/NCBI
|
|
13
|
Kuiper GG, Carlsson B, Grandien K, et al:
Comparison of the ligand binding specificity and transcript tissue
distribution of estrogen receptors alpha and beta. Endocrinology.
138:863–870. 1997.PubMed/NCBI
|
|
14
|
Pedersen SB, Bruun JM, Hube F, Kristensen
K, Hauner H and Richelsen B: Demonstration of estrogen receptor
subtypes alpha and beta in human adipose tissue: influences of
adipose cell differentiation and fat depot localization. Mol Cell
Endocrinol. 182:27–37. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu MM, Albanese C, Anderson CM, et al:
Opposing action of estrogen receptors alpha and beta on cyclin D1
gene expression. J Biol Chem. 277:24353–24360. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vahlquist A, Rask L, Peterson PA and Berg
T: The concentrations of retinol-binding protein, prealbumin, and
transferrin in the sera of newly delivered mothers and children of
various ages. Scand J Clin Lab Invest. 35:569–575. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Michaelsson G, Vahlquist A, Juhlin L,
Mellbin T and Bratt L: Zinc and vitamin A: serum concentrations of
zinc and retinol-binding protein (RBP) in healthy adolescents.
Scand J Clin Lab Invest. 36:827–832. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vahlquist A, Johnsson A and Nygren KG:
Vitamin A transporting plasma proteins and female sex hormones. Am
J Clin Nutr. 32:1433–1438. 1979.PubMed/NCBI
|
|
19
|
Suh JB, Kim SM, Cho GJ, Choi KM, Han JH
and Taek Geun H: Elevated serum retinol-binding protein 4 is
associated with insulin resistance in older women. Metabolism.
59:118–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
An C, Wang H, Liu X, et al: Serum
retinol-binding protein 4 is elevated and positively associated
with insulin resistance in postmenopausal women. Endocr J.
56:987–996. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kloting N, Graham TE, Berndt J, et al:
Serum retinol-binding protein is more highly expressed in visceral
than in subcutaneous adipose tissue and is a marker of
intra-abdominal fat mass. Cell Metab. 6:79–87. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rodriguez-Cuenca S, Monjo M, Proenza AM
and Roca P: Depot differences in steroid receptor expression in
adipose tissue: possible role of the local steroid milieu. Am J
Physiol Endocrinol Metab. 288:E200–E207. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tan BK, Chen J, Lehnert H, Kennedy R and
Randeva HS: Raised serum, adipocyte, and adipose tissue
retinol-binding protein 4 in overweight women with polycystic ovary
syndrome: effects of gonadal and adrenal steroids. J Clin
Endocrinol Metab. 92:2764–2772. 2007. View Article : Google Scholar
|
|
24
|
Whitman MM, Harnish DC, Soprano KJ and
Soprano DR: Retinol-binding protein mRNA is induced by estrogen in
the kidney but not in the liver. J Lipid Res. 31:1483–1490.
1990.PubMed/NCBI
|
|
25
|
Janke J, Engeli S, Boschmann M, et al:
Retinol-binding protein 4 in human obesity. Diabetes. 55:2805–2810.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tschoner A, Sturm W, Engl J, et al:
Retinol-binding protein 4, visceral fat, and the metabolic
syndrome: effects of weight loss. Obesity (Silver Spring).
16:2439–2444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsuda M, Masui F and Mori T: Neonatal
estrogenization leads to increased expression of cellular retinol
binding protein 2 in the mouse reproductive tract. Cell Tissue Res.
316:131–139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
MacLaren R, Cui W and Cianflone K:
Visfatin expression is hormonally regulated by metabolic and sex
hormones in 3T3-L1 pre-adipocytes and adipocytes. Diabetes Obes
Metab. 9:490–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou J and Seidel ER: Estrogens induce
visfatin expression in 3T3-L1 cells. Peptides. 31:271–274. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yi KW, Shin JH, Seo HS, et al: Role of
estrogen receptor-alpha and -beta in regulating leptin expression
in 3T3-L1 adipocytes. Obesity (Silver Spring). 16:2393–2399. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Watanobe H and Suda T: A detailed study on
the role of sex steroid milieu in determining plasma leptin
concentrations in adult male and female rats. Biochem Biophys Res
Commun. 259:56–59. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kristensen K, Pedersen SB and Richelsen B:
Regulation of leptin by steroid hormones in rat adipose tissue.
Biochem Biophys Res Commun. 259:624–630. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen YH, Lee MJ, Chang HH, Hung PF and Kao
YH: 17 beta-estradiol stimulates resistin gene expression in 3T3-L1
adipocytes via the estrogen receptor, extracellularly regulated
kinase, and CCAAT/enhancer binding protein-alpha pathways.
Endocrinology. 147:4496–4504. 2006. View Article : Google Scholar
|
